These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 1697132)

  • 41. Prevalence of HBV and HDV markers in families of patients with HBsAg+ chronic liver disease.
    Ciampi R; Abrescia N; Villari R; Memoli AM; Isabella L; Picciotto L
    Prog Clin Biol Res; 1987; 234():381-2. PubMed ID: 3628390
    [No Abstract]   [Full Text] [Related]  

  • 42. Hepatitis delta infection among multiply-transfused hemophiliacs.
    Lemon SM; Becherer PR; Wang JG; White GC; Lesesne H; Janco RL; Hanna WT; Davis C; Johnson CA; Poon MC
    Prog Clin Biol Res; 1991; 364():351-60. PubMed ID: 2020710
    [No Abstract]   [Full Text] [Related]  

  • 43. Endemic hepatitis delta virus infection in a Greek community.
    Hadziyannis SJ; Hatzakis A; Papaioannou C; Anastassakos C; Vassiliadis E
    Prog Clin Biol Res; 1987; 234():181-202. PubMed ID: 2442775
    [No Abstract]   [Full Text] [Related]  

  • 44. Role of delta infection in the progression to chronicity of acute HBsAg positive hepatitis.
    Caporaso N; del Vecchio-Blanco C; Servillo F; Suozzo R; Pignalosa G; Manzillo G; Maio G; Izzo CM; Coltorti M
    Gastroenterol Clin Biol; 1984; 8(8-9):646-50. PubMed ID: 6489684
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Long-term results of treatment of chronic active hepatitis B with vidarabine monophosphate].
    Causse X; Guérou V; Rougier P; Trépo C
    Gastroenterol Clin Biol; 1993; 17(2):144-5. PubMed ID: 7684714
    [No Abstract]   [Full Text] [Related]  

  • 46. Therapy of chronic type B hepatitis with adenine arabinoside and adenine arabinoside monophosphate.
    Hoofnagle JH
    J Hepatol; 1986; 3 Suppl 2():S73-80. PubMed ID: 2439579
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Presence of delta antigen in liver biopsies of HBsAg positive patients with chronic liver diseases living in the Naples area.
    Picciotto L; Abrescia N; Ciampi R
    Boll Soc Ital Biol Sper; 1983 Jan; 59(2):189-91. PubMed ID: 6860493
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Virostatic therapy with adenine arabinoside].
    Werner TG
    Med Klin; 1978 Oct; 73(43):2. PubMed ID: 82198
    [No Abstract]   [Full Text] [Related]  

  • 49. Effect of steroids and adenine-arabinoside (araA) on growth and HBsAg production of a human hepatoma cell line.
    Clementi M; Bagnarelli P; Pauri P
    Arch Virol; 1983; 75(1-2):137-41. PubMed ID: 6187317
    [No Abstract]   [Full Text] [Related]  

  • 50. Chronic hepatitis B and adenine arabinoside monophosphate (Ara-AMP).
    Novick DM
    Ann Intern Med; 1988 Mar; 108(3):492-3. PubMed ID: 2449111
    [No Abstract]   [Full Text] [Related]  

  • 51. [Preliminary animal experimental results and clinical experiences with the antiviral agent adenine arabinoside monophosphate in encephalitis from herpes group and varicella-zoster infections].
    Sauer O; Huth E; Lenard HG; Schneider H; von Haselberg L; Nettesheim HJ; Werner GT
    Monatsschr Kinderheilkd (1902); 1980 May; 128(5):248-50. PubMed ID: 6158680
    [No Abstract]   [Full Text] [Related]  

  • 52. Iontophoretic application of adenine arabinoside monophosphate for the treatment of herpes simplex virus type 2 skin infections in hairless mice.
    Kwon BS; Hill JM; Wiggins C; Tuggle C
    J Infect Dis; 1979 Dec; 140(6):1014. PubMed ID: 94335
    [No Abstract]   [Full Text] [Related]  

  • 53. Antiviral treatment in chronic hepatitis B. Data of 5 prospectively controlled randomized trials.
    Müller R; Klein H; Vido I; Niehoff G; Lautz HU; Gebel M; Schmidt FW
    J Hepatol; 1986; 3 Suppl 2():S217-23. PubMed ID: 2439573
    [No Abstract]   [Full Text] [Related]  

  • 54. Chronic delta infection in a patient without detectable HBsAg in serum.
    Buti M; Esteban R; Jardi R; Allende H; Guardia J; Roggendorf M
    Hepatology; 1988; 8(4):985-6. PubMed ID: 3391528
    [No Abstract]   [Full Text] [Related]  

  • 55. Diminished responsiveness of homosexual men to antiviral therapy for HBsAg-positive chronic liver disease.
    Novick DM; Lok AS; Thomas HC
    J Hepatol; 1985; 1(1):29-35. PubMed ID: 2414358
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Activity of fludarabine monophosphate in patients with advanced mycosis fungoides: a Southwest Oncology Group study.
    Von Hoff DD; Dahlberg S; Hartstock RJ; Eyre HJ
    J Natl Cancer Inst; 1990 Aug; 82(16):1353-5. PubMed ID: 1696322
    [No Abstract]   [Full Text] [Related]  

  • 57. Evaluation of fludarabine phosphate in renal cell carcinoma: a Southwest Oncology Group Study.
    Balducci L; Blumenstein B; Von Hoff DD; Davis M; Hynes HE; Bukowski RM; Crawford ED
    Cancer Treat Rep; 1987 May; 71(5):543-4. PubMed ID: 2436773
    [No Abstract]   [Full Text] [Related]  

  • 58. Phase II study of fludarabine phosphate in previously untreated patients with hepatoma: a Southwest Oncology Group Study.
    Harvey WH; Fleming TR; Beltran G; Saiers JH; Oishi N; Von Hoff DD
    Cancer Treat Rep; 1987 Nov; 71(11):1111-2. PubMed ID: 2445482
    [No Abstract]   [Full Text] [Related]  

  • 59. Ineffectiveness of adenine arabinoside and adenine arabinoside 5'-monophosphate in simian varicella infection.
    Soike KF; Felsenfeld AD; Gibson S; Gerone PJ
    Antimicrob Agents Chemother; 1980 Jul; 18(1):142-7. PubMed ID: 6158291
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Vidarabine phosphate in the treatment of active chronic hepatitis B. A confirmed hope].
    Ouzan D
    Rev Prat; 1992 Jun; 42(11):1383-6. PubMed ID: 1382310
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.